Vendor, Las Vegas, NV, part of Unitedhealth Group Incorporated
Optum Frontier Therapies Ii, LLC
UEI LDSEJNND3DQ5, CAGE 9KH53
2 awards and $116,747 obligated between July 30, 2026 and September 3, 2026, 0% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Pharmaceutical Preparation ManufacturingNAICS 325412 | $116,747 |
How it wins
Awards by competition, set-aside and type.
| Not Competed Under SAP | 2 |
| Purchase Order | 2 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 36C26126P1008Purchase Order, July 30, 2026, Not Competed Under SAP, 1 offers | 261-Network Contract Office 21Department of Veterans Affairs | Sephience (Sepiapterin) MedsNAICS 325412, PSC 6505 | $58,374 |
| 36C26126P1178Purchase Order, September 3, 2026, Not Competed Under SAP, 1 offers | 261-Network Contract Office 21Department of Veterans Affairs | Sephience (Sepiapterin) Oral PowderNAICS 325412, PSC 6505 | $58,374 |
- Places of performance
- Nevada
- Product and service codes
- 6505 Drugs and Biologicals
- Transactions
- 3 across 2 awards